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A B S T R A C T
Studies in vivo have suggested the involvement of CREB-regulated transcription coactivator (CRTC)2 on ACTH-
induced transcription of the key steroidogenic protein, Steroidogenic Acute Regulatory (StAR). The present study
uses two ACTH-responsive adrenocortical cell lines, to examine the role of CRTC on Star transcription. Here we
show that ACTH-induced Star primary transcript, or heteronuclear RNA (hnRNA), parallels rapid increases in
nuclear levels of the 3 isoforms of CRTC; CRTC1, CRTC2 and CRTC3. Furthermore, ACTH promotes recruitment
of CRTC2 and CRTC3 by the Star promoter and siRNA knockdown of either CRTC3 or CRTC2 attenuates the
increases in ACTH-induced Star hnRNA. Using pharmacological inhibitors of PKA, MAP kinase and calcineurin,
we show that the eﬀects of ACTH on Star transcription and CRTC nuclear translocation depend predominantly on
the PKA pathway. The data provides evidence that CRTC2 and CRTC3, contribute to activation of Star tran-
scription by ACTH, and that PKA/CRTC-dependent pathways are part of the multifactorial mechanisms reg-
ulating Star transcription.
1. Introduction
Glucocorticoid hormone release from the adrenal gland is essential
for maintaining normal metabolic function and survival during severe
stress (Cole et al., 1995; Whitehead et al., 2013). In basal (unstressed)
conditions, glucocorticoids are secreted rhythmically, with both circa-
dian (daily) and ultradian (pulsatile) variations (Park et al., 2013;
Weitzman et al., 1971; Tapp et al., 1984). The episodic nature of glu-
cocorticoid secretion is critical for homeostasis, and its alteration can
result in changes in tissue steroid responsiveness, resulting in neu-
roendocrine, behavioural and metabolic dysfunction (Deuschle et al.,
1997; van den Berg et al., 1995; Qian et al., 2012). Glucocorticoid
circadian and ultradian rhythmicity follow preceding changes in cir-
culating ACTH. As with other steroid hormones, stimulation of gluco-
corticoid secretion by ACTH requires de novo synthesis. These ACTH-
dependent glucocorticoid secretory episodes in vivo, are associated with
rapid transcription of genes encoding steroidogenic proteins in the zona
fasciculata of the adrenal cortex (Sewer and Waterman, 2002; Spiga
et al., 2011a,b; Liu et al., 2013; Spiga et al., 2017), including the rate-
limiting steroidogenic acute regulatory (StAR) protein (Stocco and
Clark, 1996). Although initiation of steroidogenesis following ACTH
stimulation depends on rapid post-translational modiﬁcations of StAR
(Arakane et al., 1997), this protein is short-lived (Artemenko et al.,
2001) and transcriptional episodes are essential for maintaining ade-
quate mRNA and protein levels for subsequent secretory episodes
(Ferguson, 1963; Garren et al., 1965; Clark et al., 1997).
The mechanism of action of ACTH involves cAMP/PKA-dependent
mechanisms (Cammas et al., 1995; Schimmer, 1972; Clark et al., 2001),
and, to a lesser extent, the Mitogen-activated protein kinase (MAPK)
pathway (Gyles et al., 2001; Lotﬁ et al., 2000; Rocha et al., 2003;
Winnay and Hammer, 2006). This results in activation of transcription
factors responsible for inducing Star transcription, including
https://doi.org/10.1016/j.mce.2019.110612
Received 3 June 2019; Received in revised form 6 September 2019; Accepted 4 October 2019
∗ Corresponding author. Diabetes Research Group, School of Life Course Sciences, 2.28 Henriette Raphael, Guy's Campus, King's College London, London, SE1 1UL,
UK.
E-mail address: lorna.smith@kcl.ac.uk (L.I.F. Smith).
Molecular and Cellular Endocrinology 499 (2020) 110612
Available online 08 October 2019
0303-7207/ © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
steroidogenic factor 1 (SF-1) and cAMP response element binding
protein (CREB) (Sandhoﬀ et al., 1998; Aesoy et al., 2002; Manna et al.,
2003; Lefrancois-Martinez et al., 2011). The transcription factor coac-
tivator, CREB-regulated transcription coactivator (CRTC, previously
known as Transducer of Regulated CREB activity; TORC), has been
shown to enhance CREB binding to the RNA polymerase II pre-initiation
complex at the promoter, through its binding to the CREB bZIP domain
(Conkright et al., 2003; Orphanides et al., 1996). Three isoforms of
CRTC have been identiﬁed, CRTC1, CRTC2 and CRTC3, (Conkright
et al., 2003; Iourgenko et al., 2003), with Crtc1 mRNA being located
predominantly in the brain, and Crtc2 and Crtc3 ubiquitously expressed
(Conkright et al., 2003; Wu et al., 2006; Watts et al., 2011; Uebi et al.,
2010). Whilst in basal conditions CRTC remains sequestered in the
cytoplasm, activation by administration of cAMP or forskolin leads to
dephosphorylation and subsequent translocation of CRTC into the nu-
cleus (Bittinger et al., 2004; Lee et al., 2015; Takemori et al., 2007),
where it is required for maximal CREB-mediated transcriptional activity
(Conkright et al., 2003; Liu et al., 2010; Wang et al., 2010). CRTC2 has
been implicated in the regulation of Star transcription in transfected
adrenocortical cells (Lee et al., 2015; Takemori et al., 2007). In vivo, in
the rat, both ACTH injection and stress rapidly (within 5–7min) induce
CRTC2 dephosphorylation and nuclear translocation in the adrenal
zona fasciculata, and is followed by an increase in Star transcription by
15min (Liu et al., 2013; Spiga et al., 2011a,b).
The above evidence strongly suggests that CRTC2 is involved in the
regulation of Star transcription. The adrenal cortex also expresses
CRTC1 and CRTC3, though levels of CRTC1 are much lower than those
of CRTC2 and CRTC3 both in rat; Fig. S1, and in humans (Conkright
et al., 2003). Thus, it is reasonable to hypothesize that, in addition to
CRTC2 (Liu et al., 2013; Takemori et al., 2007; Spiga et al., 2011a,b),
activation of the other isoforms, especially the highly expressed CRTC3,
is also involved in the transcriptional regulation of Star. The objective
of the present study was to elucidate the roles of diﬀerent CRTC iso-
forms on ACTH-regulated Star transcription and the signalling path-
ways involved in this regulation. For this purpose, we investigated the
dynamics of nuclear translocation of the three endogenous CRTC iso-
forms in response to ACTH, in relationship with the time course of Star
transcription and CREB phosphorylation in two murine adrenal cell
lines, Y1-BS1 (Watt and Schimmer, 1981), and ATC7-L (Ragazzon et al.,
2006). In contrast with the original cell line, Y1 (Yasumura et al., 1966;
Bloch and Cohen, 1960), widely used to study steroidogenesis
(Whitehouse et al., 2002; Zaidi et al., 2014; Rainey et al., 2004), the
sub-clone, Y1-BS1, is ACTH-responsive but as with the parent line, has
the disadvantage of not producing corticosterone (Parker et al., 1985).
The line ATC7-L, derived from an adrenal fasciculata tumour (induced
by targeted expression of SV40 large T antigen (Sahut-Barnola et al.,
2000)), produces corticosterone in response to physiological ACTH
concentrations, as well as episodic secretion in response to ACTH pulses
(Ragazzon et al., 2006; Hazell et al., 2019). Using these two ACTH-
responsive cell lines, we examined the physiological role of CRTC2 and
CRTC3 on Star transcription, employing siRNA knockdown, and
chromatin immunoprecipitation assays to investigate the recruitment of
CRTCs by the Star promoter.
2. Materials and methods
All chemicals were purchased from Sigma Aldrich unless otherwise
stated.
2.1. Cell cultures, transfections and treatments
Mouse adrenocortical Y1-BS1 cells (kindly provided by Dr Bernard
Schimmer, University of Toronto, ON), were cultured in MEMα (Gibco)
containing 2.5% heat-inactivated foetal bovine serum (Gibco), 15%
heat-inactivated horse serum (Gibco), 1% penicillin/streptomycin
(pen/strep). Mouse adrenocortical ATC7-L cells were cultured in
0.005% poly-L-lysine (P1399) pre-coated ﬂasks, in DMEM/F12-
GlutaMAX medium (Gibco) containing 2.5% heat-inactivated horse
serum, 2.5% heat inactivated fetal bovine serum, 1% pen/strep and 1%
insulin, transferrin and sodium selenite (ITS; Gibco) (Ragazzon et al.,
2006). Both cell lines were cultured at 37 °C under a 5% CO2-95% air
atmosphere.
For CRTC silencing experiments, Y1-BS1 cells were transfected by
electroporation (Nucleofector II, Amaxa, Lonza, Gaithersburg, MD,
USA). Six million Y1-BS1 cells per cuvette in 100 μl solution V, were
combined with 600 nM siRNA oligonucleotides and transfected using
program L-033, 600 nM of scrambled control #1 siRNA (Thermoﬁsher
Scientiﬁc) for control groups; 300 nM 5′-GGUCCUGGAUUUUUAG
GGAtt-3′ Crtc2 siRNA (Thermoﬁsher Scientiﬁc) plus 300 nM scrambled
control #1 siRNA for the CRTC2 knockdown group; 300 nM 5′-GACC
AAUUCUGAUUCUGCUtt-3′ Crtc3 siRNA (Thermoﬁsher Scientiﬁc) plus
300 nM scrambled control #1 siRNA for the CRTC3 knockdown group;
300 nM each, Crtc2 and Crtc3 siRNA for combined CRTC2 and CRTC3.
Following transfection, cells were cultured for 48 h in supplemented
MEMα prior to changing to supplement-free media containing 0.1%
BSA for 1 h (Y1-BS1) or 24 h (ATC7-L cells) before experimentation.
Cells were stimulated with either 10 nM synthetic ACTH (ACTH-
(1–39)), 1 mM 8-Br-cAMP, 100 nM of phorbol 12-myristate 13-acetate
(PMA) or 3 nM epidermal growth factor (EGF) for the times indicated.
In experiments involving inhibitors, cells were pre-incubated for 15min
with 10 μM of the PKA inhibitor, H89, 1 μM the MEK1/MEK2 inhibitor,
UO126 or 5 μM the calcineurin inhibitor, cyclosporine A (CsA), or ve-
hicle (ﬁnal concentration 0.5% DMSO).
2.2. Rat adrenal cell isolation
Female Sprague Dawley rats were decapitated following CO2 seda-
tion, adrenal glands removed, decapsulated and quartered, and then
digested with collagenase Type II, 2 mg/ml in DMEM/HEPES (Gibco),
containing 1% pen/strep, 1% BSA fraction V, 0.02% Deoxyribonuclease
I, for 20min at 37 °C, 95% air/5%CO2 under agitation. Tissue was then
sedimented, washed and resuspended in DMEM/HEPES containing 1%
Abbreviations
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CRTC CREB-regulated transcription coactivator
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pen/strep, 1% BSA, 0.002% Deoxyribonuclease I and 0.01% Trypsin
inhibitor, and mechanically dispersed by aspiration/release with a
syringe attached to 3mm tubing. The supernatant containing dispersed
cells was ﬁltered through a 100 μm nylon gauze, and the procedure
repeated until the media became clear. A second collagenase incubation
and dispersion was performed on undigested tissue. Pooled supernatant
was centrifuged at 100×g, cell pellets resuspended and preincubated
for 1 h in 20ml DMEM/HEPES containing 0.1% BSA and 1% pen/strep,
before resuspending in fresh medium at 250,000 cell/ml. Aliquots
(1 ml) were incubated at 37 °C for the time periods and conditions in-
dicated. Incubations were terminated by placing vials on ice, then cells
pelleted by centrifugation for RNA isolation.
2.3. RNA isolation and RT-qPCR
Cells were harvested in TRIzol reagent (Thermoﬁsher Scientiﬁc) and
RNA extracted using phase separation with chloroform. Total RNA was
puriﬁed from the aqueous phase using RNeasy mini kit reagents and
column DNase digestion (Qiagen, Valencia, CA, USA), per manufacturer
instructions. Complementary (c)DNA was reverse transcribed from
1000 ng of RNA as previously described (Liu et al., 2008). qPCR primers
for murine Star primary transcript (prior to splicing to mRNA), or
heteronuclear RNA (hnRNA), were designed spanning an intronic-
exonic region: Forward 5′-TGTCTCGCTCGGGGTCACACA-3′, Reverse 5′-
AGGCAGGGGCACCTCAAGCT-3′, Invitrogen). PCR reactions were per-
formed using power SYBR green PCR mix (ThermoFisher Scientiﬁc),
166 nM of each primer and 2 μl cDNA, ﬁnal volume 15 μl, in a spec-
troﬂuorometric thermal cycler 7900 HT Fast real-time PCR system
(ThermoFisher Scientiﬁc) as previously described (Liu et al., 2010).
Brieﬂy, samples underwent denaturation at 50 °C for 2min, 95 °C for
10min, followed by 45 cycles at 95 °C for 15 s and 60 °C for 1min
hnRNA levels were calculated using relative quantiﬁcation by standard
curve, normalised to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) mRNA (murine Gapdh mRNA: Forward 5′-CCATCACTGCCAC
CCAGAAGA-3′, Reverse 5′-GACACATTGGGGGTAGGAACA-3′, In-
vitrogen), as determined in separate qRT-PCR reactions. Absence of
detection when omitting the reverse transcription enzyme Superscript
III (Invitrogen) indicated a lack of genomic DNA contamination.
2.4. Western immunoblot analysis
Following treatment, cells were washed and collected in ice-cold
PBS containing protease and phosphatase inhibitors (Pierce, Rockford,
IL, USA). Nuclear and cytosolic proteins were extracted using the NE-
PER Nuclear and Cytoplasmic Extraction Reagent kit (Pierce), whole
cell protein extracts were obtained using Tissue Protein Extraction
Reagent (T-PER; Pierce), per manufacturer instructions. Protein sam-
ples (18 μg) were separated in Tris-Glycine gels, transferred to PVDF
membranes and incubated overnight at 4 °C with the following primary
antibodies: rabbit anti-CRTC1 (1:1000 dilution; Cell Signalling,
Danvers, MA, USA), rabbit anti-CRTC2 (1:2000; ST1099 EMD Millipore
Billerica, MA, USA), rabbit anti-CRTC3 (1:1000; Cell Signalling), mouse
anti-phospho-CREB (1:500; 10E9 EMD Millipore), goat anti-HDAC1
(1:1000; C-19, Santa Cruz Biotech., Dallas, TX, USA), goat anti-β-actin
(1:1000; I-19, Santa Cruz Biotech.) or goat anti-vinculin (1:5000; N19,
Santa Cruz Biotech). Membranes were washed and incubated for 1 h at
room temperature with a horseradish peroxidase-conjugated secondary
antibody at 1:10000 (donkey anti-rabbit) or 1:5000 (donkey anti-goat
and goat anti-mouse) dilution. Detection of immunoreactive bands was
performed using ECL Plus TM reagents (GE Amersham Biosciences,
Pittsburgh, PA, USA) followed by exposure to BioMax MR ﬁlm
(Eastman Kodak, Rochester, NY, USA). Band intensity was semi-quan-
tiﬁed using ImageJ (freely available https://imagej.nih.gov/ij/
download.html). Results are expressed as fold-change over the control
values after correction for protein loading using HDAC1 for the nucleus,
β-actin or Vinculin for cytoplasm and whole cell.
2.5. Chromatin immunoprecipitation assay
Following ACTH treatment, ATC7-L (1.7× 106) cells were ﬁxed
with 1% formaldehyde, quenched with glycine (0.125M ﬁnal con-
centration), washed with PBS, collected into tubes and pelleted by
centrifugation. For pCREB and CRTC2 immunoprecipitation, chromatin
was sheared by sonication, adapted from work described previously
(Evans et al., 2013). Brieﬂy, cell pellets were resuspended in Lysis
buﬀer (0.5% SDS, Invitrogen; 1% Triton x-100; 10mM KCl; 1.5 mM
MgCl2; 1 mM EDTA pH 7.4, Ambion; 20mM HEPES pH 7.3, Thermo-
Fisher Scientiﬁc) with protease/phosphatase inhibitors, and incubated
on ice before Dounce homogenisation (Kontes, Kimble Chase, Vineland,
NJ, USA). Following centrifugation, nuclear pellets were resuspended
in Sonication buﬀer (0.2% SDS, 0.1M KCl, 1.5mM MgCl2, 1 mM EDTA,
20mM HEPES pH 7.3) with protease/phosphatase inhibitors, and then
sonicated by Bioruptor (Diagenode, Liège, Belgium) to generate
0.25–1 kb chromatin fragments. In a diﬀerent set of experiments for
CRTC3 immunoprecipitation, conducted at the University of Bristol
laboratory, chromatin fragmentation was achieved using micrococcal
nuclease (MNase), as described previously (Stubbs et al., 2018).
Immunoprecipitation was performed as previously described
(Grontved et al., 2013; Grontved et al., 2010). DNA concentration was
determined by absorbance at 260 nm and samples were diluted in ChIP
dilution buﬀer (0.01% SDS; 1.1% Triton x-100; 1.2 mM 0.5M EDTA;
17 mM Tris-HCl pH 8.1; 170 mM NaCl) at equal DNA amounts (max
0.1% SDS), then pre-cleared by incubation with Protein A/G plus
agarose beads (Santa Cruz Biotech). Protein G Magnetic beads (Active
Motif, Carlsbad, CA, USA) were linked to either anti-CRTC2 antibody
(1.2 μg; Bethyl, Mongomery, TX, USA), a 1:1 cocktail of anti-pCREB
antibodies (6 μg; 06–519 and ChIPAb+, Millipore) (Liu et al., 2011),
anti-CRTC3 antibody (2 μg; ab91654, AbCam, Cambridgeshire, UK)
(Jurek et al., 2015), or ChIP-grade non-speciﬁc rabbit IgG (4 μg; Cell
Signalling) in Low Salt buﬀer (0.1% SDS; 1% Triton x-100; 2mM EDTA;
20mM Tris HCl pH8.1; 150mM NaCl). Pre-cleared chromatin
(28–43 μg PCREB/CRTC2, 12–25 μg CRTC3) was incubated with anti-
body-linked beads (50 μl beads/ml chromatin) overnight at 4 °C, then
washed in Low Salt buﬀer, High Salt buﬀer (0.1% SDS; 1% Triton x-
100; 2mM EDTA; 20mM Tris HCl pH8.1; 500mM NaCl), LiCl buﬀer
(0.25M LiCl; 1% IGEPAL; 1% sodium deoxycholate; 1 mM EDTA;
10mM Tris-HCl pH8.1) and Tris-EDTA (TE) buﬀer (10mM Tris-HCl,
1 mM EDTA pH8.1). Samples were eluted in Elution buﬀer (10mM Tris-
HCl pH 8.0, 300mM NaCl, 55mM EDTA, 0.5% SDS) with Proteinase K
at 65 °C overnight, then chromatin resuspended in water following
phenol-chloroform-isoamyl alcohol extraction. Samples were stored at
−80 °C prior to DNA quantiﬁcation by qRT-PCR, as detailed above.
Primers spanning the three putative CRE sites at −104 bp to−5 bp of
the Star promoter (Forward 5′-TTCCATCCTTGACCCTCTGC-3′, Reverse
5′-AGATCAAGTGCGCTGCCTTA-3′, Invitrogen) were designed using
NCBI Primer-BLAST, as determined via NCBI GenBank. Promoter pull-
down was quantiﬁed using mouse genomic DNA, normalised to the
total levels in the chromatin input (promoter content in chromatin not
subjected to immunoprecipitation).
2.6. Statistical analyses
All data are expressed as mean ± SEM of values obtained from a
minimum of three independent experiments. Normal distribution of the
data and homogeneity of variance were veriﬁed using the Shapiro-Wilk
test and Normal Q-Q plots, and the LEVENE test, respectively. Data
were analysed using one-way ANOVA, Welch ANOVA or two-way
ANOVA, as indicated in the ﬁgure legend. When appropriate, one- or
two-way ANOVA was followed by Fisher Least Signiﬁcant Diﬀerence
(Fisher LSD) post-hoc test, Welch ANOVA was followed by the Dunnett
T3 post-hoc test. Statistical signiﬁcance was set at P≤ 0.05, with a
trend deﬁned as P≤ 0.1.
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3. Results
3.1. Time course of the eﬀect of ACTH on Star transcription, CREB
phosphorylation and CRTC translocation in Y1-BS1 and ATC7-L cells
The dynamics of Star transcription in response to ACTH were de-
termined by measuring the levels of Star primary transcript (Star
hnRNA). ACTH induced an overall increase in Star hnRNA levels both in
Y1-BS1 and ATC7-L cells (P < 0.001; Fig. 1A and B), with no changes
detected in the ﬁrst 5–7min, whereas a signiﬁcant increase was ob-
served at 15–60min. Concomitant with the increase in Star hnRNA,
ANOVA analysis revealed a signiﬁcant eﬀect of ACTH on pCREB in both
cell lines (Y1-BS1: P=0.02; Fig. 1C ATC7-L: P=0.002; Fig. 1D). In Y1-
BS1 cells, nuclear pCREB transiently increased 2.2-fold by 7min,
peaking at 15min. In ATC7-L cells, pCREB increased by 7.5-fold at
15min and remained signiﬁcantly elevated at 60min (5.8-fold).
To investigate whether these changes in pCREB and Star transcrip-
tion are associated with diﬀerential changes in CRTC subtype nuclear
translocation, we measured the dynamics of cytosolic and nuclear levels
of CRTC1, CRTC2 and CRTC3. ACTH had no signiﬁcant eﬀect on cy-
tosolic CRTC1, CRTC2 or CRTC3 levels in Y1-BS1 (Fig. 2A; data not
shown) or ATC7-L cells (Fig. 3A; data not shown). Y1-BS1 cells ex-
hibited a signiﬁcant overall increase in nuclear translocation of CRTC1
(P=0.04), CRTC2 (P=0.01) and CRTC3 (P=0.04; Fig. 2A and B).
Nuclear levels of CRTC3 were already signiﬁcantly increased by 3min,
whilst nuclear levels of CRTC1 and CRTC2 were signiﬁcantly increase
at 7min. A signiﬁcant overall eﬀect of ACTH on nuclear CRTC1 and
CRTC3 was also detected in ATC7-L cells (CRTC1: P=0.05; CRTC3:
P=0.02; Fig. 3A and B), with nuclear levels of CRTC3 also signiﬁcantly
increased by 3min. Despite an increase in nuclear levels of CRTC2 in
each one of four experiments (range 1.5–5.3-fold at 3min), the changes
were not signiﬁcant due to high variability in the magnitude of the
eﬀect across experiments (P=0.22).
3.2. ACTH induces rapid association of pCREB, CRTC2 and CRTC3 at the
proximal Star promoter in ATC7-L cells
The increases in nuclear CRTCs, preceding increases in Star hnRNA,
suggest an involvement of the coactivators in the initiation of Star
transcription. To determine whether CRTC2 and CRTC3 can interact
with the Star promoter, we used the adrenocortical cell line, ATC7-L,
and ChIP assays to measure recruitment of pCREB and CRTC proteins
by the Star promoter. Recruitment of CRTC1 could not be measured
because of the lack of a suitable antibody for ChIP. ACTH signiﬁcantly
increased the binding of pCREB (P=0.04; Fig. 4A) and CRTC2
(P=0.04; Fig. 4B) at the Star promoter. No increases in binding were
detected at 7min, but by 30min, there was a signiﬁcant increase above
basal levels for both pCREB (P=0.02) and CRTC2 (P=0.02). Im-
munoprecipitation of the Star promoter by the CRTC3 antibody also
revealed a signiﬁcant eﬀect of ACTH on CRTC3 binding (P < 0.001;
Fig. 4C). Binding of CRTC3 to the Star promoter was detected by 15min
(P=0.001), the earlier point measured, and remained at similar levels
at 30min (P < 0.001).
3.3. Knockdown of CRTC2 and CRTC3 attenuates Star transcription
The involvement of the diﬀerent CRTC subtypes on ACTH-induced
Star transcription was investigated further using siRNA oligonucleo-
tides to inhibit the expression of CRTC1-3 in the adrenocortical cell
line, Y1-BS1. While technical diﬃculties impaired CRTC1 knockdown,
transfection with Crtc2 and Crtc3 siRNA oligonucleotides, alone or in
combination eﬀectively reduced the respective CRTC in whole cell
protein extracts, for CRTC2 (P=0.01; Fig. 5B) and CRTC3 (P=0.002;
Fig. 5C) protein levels. Transfection with Crtc2 siRNA decreased CRTC2
Fig. 1. Time course of the eﬀect of ACTH on Star
hnRNA and pCREB in Y1-BS1 and ATC7-L cells.
Y1-BS1 (A and C) and ATC7-L (B and D) cells were
treated with 10 nM ACTH. Data points represent the
mean ± SEM of Star hnRNA (A-B) and pCREB (C-
D). Star hnRNA was normalised to GapdhmRNA and
is expressed as fold-changes of time 0 (n= 3–6/
time point). In C, pCREB was measured in the nu-
clear extract, was normalised to HDAC, and is ex-
pressed as fold-changes of time 0 (n= 4–5/time
point). In D, pCREB was measured in the whole cell
extract, was normalised to vinculin, and is ex-
pressed as fold-change of time 0 (n=3/time point).
Data in A were analysed using one-way ANOVA
followed by Fisher LSD post-hoc test; data in B, C
and D were analysed using Welch ANOVA followed
by Dunnett T3 post-hoc test. *P≤ 0.05, **P≤ 0.01,
***P≤ 0.001 vs time 0.
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protein by 75.3% ± 8.4 (P=0.02 vs non-coding siRNA sequence,
siNC; Fig. 5B), whilst Crtc3 siRNA transfection decreased CRTC3 pro-
tein by 49.2% ± 14.3 (P=0.03 vs siNC; Fig. 5C). Furthermore, there
was no signiﬁcant diﬀerence in whole cell CRTC2 and CRTC3 protein
levels when cells were transfected with the heterologous siRNA,
conﬁrming speciﬁcity of the siRNA used. Knockdown of CRTC2 and
CRTC3, alone or combined, did not aﬀect CRTC1 protein levels
(P=0.49; Fig. 5A).
Star hnRNA levels were then measured either following 45min
treatment with 10 nM ACTH or vehicle (Fig. 5D). Two-way ANOVA
Fig. 2. Time course of the eﬀects of ACTH on
nuclear levels of CRTC in Y1-BS1 cells. Cells
were treated with 10 nM ACTH. (A)
Representative Western immunoblot of cyto-
plasmic and nuclear CRTC1, CRTC2 and CRTC3
levels. (B) Semi-quantiﬁcation of Western im-
munoblot data expressed as fold-change of time
0. Data are the mean ± SEM of nuclear levels of
CRTC1, CRTC2, and CRTC3, normalised to
HDAC (n = 4/time point). Data were analysed
using one-way ANOVA followed by Fisher LSD
post-hoc test. *P ≤ 0.05, **P≤ 0.01, vs time 0.
Fig. 3. Time course of the eﬀects of ACTH on nuclear levels of CRTC in ATC7-L cells. Cells were treated with 10 nM ACTH. (A) Representative Western
immunoblot of cytoplasmic and nuclear CRTC1, CRTC2 and CRTC3 levels. (B) Semi-quantiﬁcation of Western immunoblot data expressed as fold-change of time 0.
Data are the mean ± SEM of nuclear levels of CRTC1, CRTC2, and CRTC3, normalised to HDAC (n = 4/time point). Data were analysed using Welch ANOVA
followed by Dunnett T3 post-hoc test. *P≤ 0.05 vs time 0.
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revealed an overall signiﬁcant eﬀect for both ACTH and siRNA on Star
hnRNA (P < 0.001 and P= 0.03, respectively), but no interaction
(P=0.15). ACTH increased Star hnRNA levels in siNC cells
(P < 0.001), an eﬀect which was signiﬁcantly attenuated in cells
transfected with either Crtc2 or Crtc3 siRNA, or their combination.
Although ACTH-stimulated values were still signiﬁcantly higher than
the respective basal (Crtc2 siRNA: P=0.002; Crtc3 siRNA: P = 0.002;
Crtc2+Crtc3 siRNA: P = 0.002), responses to ACTH were signiﬁcantly
lower than in siNC (Crtc2 siRNA: P=0.05; Crtc3 siRNA: P=0.004). No
additivity was observed between the inhibitory eﬀect of Crtc2 and Crtc3
siRNAs on ACTH-stimulated Star hnRNA, with the combined eﬀect
being similar to that of the individual oligonucleotides (P=0.004,
Fig. 4. ACTH-induced binding of pCREB, CRTC2 and CRTC3 to the Star promoter in ATC7-L cells. Cells were treated with 10 nM ACTH prior to chromatin
immunoprecipitation by antibodies for pCREB (A), CRTC2 (B) and CRTC3 (C) proteins and normal rabbit IgG. Binding of each protein target to the Star promoter was
calculated as percentage pulldown of the input. Data represent the mean ± SEM of data obtained in 3–4 independent experiments. pCREB, CRTC2 and CRTC3 data
were analysed using one-way ANOVA followed by Fisher LSD post-hoc test. IgG data were analysed using Welch ANOVA (A-B) and one-way ANOVA (C). *P≤ 0.05,
***P < 0.001 vs 0min.
Fig. 5. Eﬀect of CRTC2 and CRTC3 silencing on ACTH-induced increases in Star hnRNA levels in Y1-BS1 cells. Y1-BS1 cells were transfected with non-coding
siRNA (siNC) or siRNA oligonucleotides for CRTC2 (siCRTC2), CRTC3 (siCRTC3), or both (siCRTC2+3), 48 h prior to treatment with 10 nM ACTH for 45min. (A, B
and C) Eﬃcacy of silencing determined by Western immunoblot and semi-quantiﬁcation of the levels of whole cell CRTC1, CRTC2 and CRTC3, normalised to actin,
expressed as fold-change levels of the siNC transfected control group. No eﬀect on CRTC1 levels was observed following transfection of siCRTC1 oligonucleotides
(data not shown). (D) Eﬀect of CRTC siRNAs on Star hnRNA levels, normalised to Gapdh mRNA and expressed as fold-change of siNC transfected controls. Data are
the mean ± SEM of data obtained in 3 independent experiments. Data in A, B and C were analysed using one-way ANOVA followed by Fisher LSD post-hoc test; data
in D were analysed using two-way ANOVA followed by Fisher LSD post-hoc test. *P ≤ 0.05, **P ≤ 0.01, ***P≤ 0.001 vs untreated control. #P≤ 0.05 vs ACTH-
treated siNC control.
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compared to siNC cells). No signiﬁcant diﬀerences in basal Star hnRNA
levels between siRNA treatment groups were found.
3.4. Stimulation of cAMP, but not of MAPK or PKC pathways, mimics the
eﬀect of ACTH on Star transcription
To test whether other signalling pathways, in addition to ACTH/
cAMP, can regulate Star transcription, Y1-BS1 and ATC7-L were treated
for 30min with either ACTH, 8-Br-cAMP, the PKC stimulator PMA, or
the MAPK stimulator EGF (Fig. 6A and B). In Y1-BS1 cells (Fig. 6A),
both ACTH (P=0.001) and 8-Br-cAMP (P < 0.001) signiﬁcantly in-
creased the levels of Star hnRNA, whilst treatment with PMA or EGF
had no eﬀect on Star hnRNA levels. In ATC7-L cells (Fig. 6B), Star
hnRNA levels also increased in cells treated with ACTH (P=0.007). In
each of the three experiments, 8-Br-cAMP increased in Star hnRNA le-
vels, but due to variability in the magnitude of the increase (range
5.4–11.0-fold), the eﬀect was not statistically signiﬁcant (P=0.23).
Consistent with the ﬁndings in Y1-BS1 cells, neither PMA nor EGF had
any eﬀect on Star hnRNA levels in ATC7-L cells. These ﬁndings were
conﬁrmed in dispersed rat adrenal cells, with both ACTH and 8-Br-
cAMP increasing Star hnRNA levels, while no eﬀect of PMA treatment
was seen (Fig. 6C).
3.5. ACTH-stimulated Star transcription is attenuated by inhibition of PKA
and MAPK activity in a cell line speciﬁc manner
To further study the signalling pathways mediating Star transcrip-
tion, murine adrenocortical cell lines were pre-treated with either ve-
hicle, the PKA inhibitor H89, the MEK inhibitor UO126, or with a
combination of both inhibitors for 15min prior to incubation with
10 nM ACTH for 30min. The inhibitors, alone or in combination, had
no signiﬁcant eﬀect on basal Star hnRNA levels (Fig. 6D–F). Both Y1-
BS1 (Fig. 6D) and ATC7-L (Fig. 6E) cells showed a signiﬁcant eﬀect of
ACTH (P < 0.001), inhibitors pre-treatment (Y1-BS1: P < 0.001;
ATC7-L: P=0.03), and a signiﬁcant interaction (Y1-BS1: P=0.01;
ATC7-L: P=0.03).
When compared with the respective basal, ACTH treatment in Y1-
BS1 cells increased Star hnRNA levels in cells pre-treated with vehicle
(P < 0.001), UO126 (P=0.03) or H89 (P=0.01), but the eﬀect of
ACTH was signiﬁcantly attenuated in cells pre-treated with H89
(P=0.02) and UO126 (P=0.01) compared vehicle pre-treatment.
Furthermore, pre-treatment with the combination of H89 and UO126
had a signiﬁcant additive inhibitory eﬀect (P < 0.001), preventing a
signiﬁcant stimulatory eﬀect of ACTH (P=0.26 vs basal). Similarly,
ACTH increased Star hnRNA levels in ATC7-L cells pre-treated with
vehicle (P=0.004), UO126 (P < 0.001) and H89 + UO126
(P=0.01) compared with respective basal values, but pre-treatment
with H89 alone only tended to reduce the stimulatory eﬀect of ACTH
(P=0.15). Compared with ACTH treatment in vehicle pre-treated
controls, ACTH-stimulated Star hnRNA levels also tended to be lower in
H89 pre-treated cells (P=0.09). The lack of a signiﬁcant eﬀect of H89
in the overall analysis was likely due to the wide range in the magni-
tude of the ACTH responses in the UO126 group, since there was a
signiﬁcant reduction when comparing ACTH-stimulated values in H89
and vehicle pre-treated groups by t-test analysis (P=0.04). In contrast
to Y1-BS1 cells, preincubation of ATC7-L cells with the MAPK inhibitor,
UO126, signiﬁcantly augmented the stimulatory eﬀect of ACTH on Star
hnRNA levels compared with ACTH in vehicle pre-treated cells
(P=0.02).
Similar to the eﬀects in the cell lines, in vehicle pre-treated col-
lagenase-dispersed rat adrenal cells (Fig. 6F) there was a signiﬁcant
eﬀect of ACTH (P=0.002), while the overall eﬀect of the inhibitors or
Fig. 6. Eﬀect of mimicry and inhibi-
tion of ACTH signalling on Star
hnRNA levels in Y1-BS1, ATC7-L and
dispersed rat adrenals cells. Star
hnRNA levels were measured either
prior to or 30min after treatment with
10 nM ACTH, 1mM 8-Br-cAMP,
100 nM PMA or 3 nM EGF in Y1-BS1
(A) and ATC7-L (B), or 60min after
treatment in dispersed rat adrenal cells
(C). For inhibition studies, Y1-BS1 cells
(D), ATC7-L (E) and dispersed rat
adrenal cells (F) were pre-incubated for
15 min with either vehicle (0.5%
DMSO), 10 μM H89, 1 μM UO126, or
10 μM H89+1 μM UO126 before ad-
dition of ACTH at a ﬁnal concentration
of 10 nM. Bars represent the
mean ± SEM of 3–6 experiments,
normalised to Gapdh mRNA and ex-
pressed as fold-change from basal ve-
hicle values. PMA treated cells in C
represent the mean of data from 2 in-
dependent experiments. Data in A were
analysed using one-way ANOVA fol-
lowed by Fisher LSD post-hoc test; data
in B were analysed using Welch
ANOVA followed by Dunnett T3 post-
hoc test. Data in D, E and F were ana-
lysed using Two-way ANOVA followed
by Fisher LSD post-hoc test. *P≤ 0.05,
**P≤ 0.01, ***P≤ 0.001 vs untreated
vehicle control. #P ≤ 0.05,
###P ≤ 0.001 vs ACTH-treated ve-
hicle control.
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their interaction was not signiﬁcant (P=0.213 and P=0.412, for in-
hibitors and interaction, respectively). As in ATC7-L cells, Star hnRNA
increases in the ACTH-treated vehicle (P=0.035) and UO126
(P=0.008) groups were signiﬁcant compared to basal, whilst pre-in-
cubation with H89, but not with UO126, blunted Star hnRNA response
to ACTH (P=0.242). Also similar to ATC7-L cells, pre-incubation with
UO126 did not inhibit but tended to increase the eﬀect of ACTH com-
pared with vehicle pre-treated cells.
3.6. Inhibition of PKA and calcineurin decreases ACTH-mediated nuclear
translocation of CRTC1, CRTC2 and CRTC3 in ATC7-L cells but not ACTH-
mediated Star transcription
To investigate the role of PKA, MEK and calcineurin on CRTC-
mediated regulation of ACTH-induced Star transcription, the eﬀect of
10 min treatment with ACTH on Star hnRNA levels and nuclear levels of
CRTC1, CRTC2 and CRTC3 were measured in ATC7-L cells pre-treated
with UO126, H89 or the calcineurin inhibitor CsA. There was a sig-
niﬁcant eﬀect of ACTH (P < 0.001) and inhibitors treatment
(P < 0.001), as well as interaction (P=0.006), on Star hnRNA levels
(Fig. 7A). ACTH signiﬁcantly increased Star hnRNA in cells pre-in-
cubated with vehicle (P < 0.001), UO126 (P=0.003) and CsA
(P < 0.001) but not in cells pre-incubated with H89 alone (P = 0.17)
or in combination with the other antagonists (H89 + UO126 + CsA:
P=0.37). Interestingly, the eﬀect of ACTH on Star hnRNA was po-
tentiated by CsA (P=0.01 vs ACTH alone), whereas the potentiation
by UO126 observed after 30min ACTH treatment (Fig. 6D) was not
present after 10min treatment.
Treatment with ACTH for 10min also exerted a signiﬁcant overall
eﬀect on nuclear levels of CRTC1 (P=0.001; Fig. 7B and C), CRTC2
(P < 0.001; Fig. 7B and D) and CRTC3 (P < 0.001; Fig. 7B and E).
Furthermore, the eﬀect of inhibitors pre-treatment was signiﬁcant for
nuclear CRTC1 (P=0.04; interaction P=0.09) and CRTC2
(P=0.006; interaction P=0.011), but not for nuclear CRTC3
(P=0.76; interaction P=0.74). ACTH signiﬁcantly increased nuclear
levels of CRTC1, CRTC2 and CRTC3 in cells pre-treated with vehicle
(CRTC1: P=0.001; CRTC2: P < 0.001; CRTC3: P=0.002) and
UO126 (CRTC1: P=0.002; CRTC2: P < 0.001; CRTC3: P=0.03),
whilst nCRTC2 levels alone were also signiﬁcantly increased in CsA pre-
treated cells (P=0.016). Furthermore, ACTH-induced levels of nuclear
CRTC1 and CRTC2 were signiﬁcantly reduced in cells treated with the
inhibitors H89 (CRTC1: P=0.02; CRTC2: P < 0.001), CsA (CRTC1:
P=0.05; CRTC2: P = 0.01) and the combined H89 + UO126 + CsA
(CRTC1: P=0.003; CRTC2: P < 0.001), when compared to cells pre-
treated with vehicle. However, H89 and CsA only tended to attenuate
the eﬀect of ACTH on nuclear levels of CRTC3 (H89: P=0.09; CsA:
P=0.13, compared with ACTH stimulation in vehicle treated cells).
Furthermore, the eﬀect of pre-treatment all 3 combined inhibitors on
ACTH-stimulated nuclear accumulation of CRTC3 was no diﬀerent from
the eﬀects of each single inhibitor (P=0.31 vs basal).
4. Discussion
This in vitro study shows that nuclear translocation of the 3 isoforms
of endogenous CRTC (CRTC1, CRTC2 and CRTC3) parallels or precedes
the increases in Star hnRNA induced by ACTH, in agreement with
previous reports of ex vivo work in rats. Using chromatin im-
munoprecipitation and siRNA knockout we now demonstrate that
CRTC2 and CRTC3 are involved in the regulation of Star transcription
by ACTH in a PKA signalling dependent manner. The use of ACTH-
responsive adrenocortical Y1-BS1 and ATC7-L cell lines allowed us to
study the eﬀect of physiological stimulator, ACTH, on endogenous
proteins, rather than cAMP analogues, as with most previous studies
(Takemori et al., 2007; Whitehouse et al., 2002; Zaidi et al., 2014;
Jefcoate et al., 2011; Manna et al., 2002). The eﬀects of ACTH on Star
transcription and on nuclear pCREB and CRTC were similar in both cell
Fig. 7. Eﬀect of inhibition of ACTH
signalling on Star hnRNA levels and
CRTC activity in ATC7-L cells. Cells
were pre-treated for 15 min with either
vehicle (0.5%DMSO), protein kinase A
inhibitor H89 (H, 10 μM), the MAP ki-
nase inhibitor UO126 (U, 1 μM) or the
calcineurin inhibitor CsA (5 μM), either
alone or in combination
(H89 + UO126 + CsA), prior to
treatment with 10 nM ACTH for
10 min. (A) RT-qPCR quantiﬁcation of
Star hnRNA, normalised to Gapdh
mRNA and expressed as fold-change
levels of the basal vehicle control. Bars
represent the mean ± SEM of 3–5 in-
dependent experiments. (B)
Representative Western immunoblot of
nuclear CRTC1, CRTC2 and CRTC3 le-
vels. Quantiﬁcation of Western im-
munoblot data of CRTC1 (C), CRTC2
(D), and CRTC3 (E); data are normal-
ised to HDAC and expressed as fold-
change of basal. Bars represent the
mean ± SEM of 3–5 independent ex-
periments. Data were analysed using
two-way ANOVA followed by Fisher
LSD post-hoc test. *P ≤ 0.05,
**P ≤ 0.01, ***P≤ 0.001 vs untreated
vehicle control. #P≤ 0.05, ##P≤ 0.01,
###P≤ 0.001 vs ACTH-treated vehicle
control.
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lines, however, the actions of signalling inhibitors diﬀered, with the
MEK inhibitor, UO126, having an inhibitory eﬀect in Y1-BS1 cells and a
potentiating eﬀect in ATC7-L cells. Interestingly, the eﬀect of signalling
inhibitors in ATC-7 cells resembles that observed in collagenase dis-
persed rat adrenal cells, suggesting that, at least in rodents, they are
more representative of normal adrenal fasciculata cells. However, re-
sistance to transfection made ATC7-L cells unsuitable for use in CRTC
knock down experiments.
Whilst in earlier studies ACTH increases Star mRNA levels within
2 h in Y1-BS1 cells (Lin et al., 2001) and by 30min in ATC7-L cells
(Ragazzon et al., 2006), measuring Star hnRNA made it possible to
show signiﬁcant transcriptional activation in response to ACTH by
15min in both cell lines. These rapid increases are consistent with
ﬁndings in rat adrenal tissue 15min after ACTH injection (Spiga et al.,
2011a,b, 2017), or cAMP incubation in Y1 cells (Lee et al., 2015;
Jefcoate et al., 2011). Consistent with the view that CREB phosphor-
ylation is critical for Star transcription (Spiga et al., 2011a,b, 2017;
Manna et al., 2003; Lefrancois-Martinez et al., 2011), ACTH treatment
induced rapid and transient increases in nuclear pCREB in both cell
lines.
Rapid ACTH-induced nuclear translocation of all 3 CRTC isoforms
(CRTC1, 2 and 3) by 10min in both Y1-BS1 cells and ATC7-L cells,
coinciding with the earliest detected increases in Star hnRNA following
ACTH exposure, supports a role for CRTC in the initiation of Star
transcription. These kinetics diﬀer from previous ﬁndings in transfected
Y1 cells, showing nuclear translocation of CRTC2, but not CRTC1 or
CRTC3, in response to cAMP stimulation (Lee et al., 2015). In keeping
with the rapid nuclear translocation of the three CRTC isoforms shown
here, using ATC7-L cells we demonstrate, for the ﬁrst time, an early
interaction of CRTC2 (by 30min) and CRTC3 (by 15min) with DNA
fragments including the −104 bp to −5 bp Star promoter region
containing three cAMP-response element (CRE) half-sites (Manna et al.,
2002). The present ﬁnding of pCREB binding to the Star promoter at
30 min ACTH incubation is consistent with previous observations in Y1
cells stimulated with cAMP analogues (Jefcoate et al., 2011). The latter
study also showed delayed (60min) CRTC2 recruitment, from which
authors concluded that CRTC2 is involved in maintaining, rather than
initiating, high rates of Star transcription. The diﬀerence between the
former (Lee et al., 2015; Jefcoate et al., 2011) and present ﬁndings
could reﬂect the use of diﬀerent cell lines, or studying the eﬀect of
ACTH on endogenous CRTC2 as opposed to the eﬀect of cAMP on
transfected protein (which may exhibit altered intracellular localisation
and bioactivity). Interestingly, in contrast to the parallel nuclear
translocation patterns of the three CRTC isoforms, extrapolation of the
ChIP time courses suggests that ACTH-induced recruitment of CRTC3
by the Star promoter, which is already maximal at 15min, could po-
tentially precede that of CRTC2. Although CRTC2 recruitment was not
measured at 15min, the lack of any promoter association at 7min
renders it unlikely that binding is maximal at 15min. Since CRTC lacks
DNA-binding activity, its recruitment by the Star promoter CRE requires
association with pCREB through its CREB binding domain (CBD) (Luo
et al., 2012). Amino acid substitution studies have shown that small
changes in key motifs of the CBD region of CRTC2 can impact its
binding aﬃnity with pCREB (Conkright et al., 2003; Luo et al., 2012).
Thus, while the similar nuclear translocation time courses of CRTC1-3
could predict parallel dynamics of recruitment to the Star promoter,
diﬀerences in pCREB aﬃnity between the three CRTC isoforms could
aﬀect the recruitment time by the Star promoter. Testing this possibility
will require further detailed analyses of the early kinetics of the three
CRTC isoform pCREB association and recruitment by the Star promoter.
Previous reports demonstrate that CRTC2 overexpression increases
Star transcription (Takemori et al., 2007), while activation of salt in-
ducible kinase (SIK) 1, which prevents activation and nuclear locali-
sation of CRTC2, inhibits Star transcription (Lin et al., 2001; Katoh
et al., 2004). We demonstrate that siRNA knockdown of CRTC2 and
CRTC3 in Y1-BS1 cells only partially inhibits ACTH stimulation of Star
hnRNA levels, directly establishing a role for CRTC mediating ACTH-
induced Star transcription. However, in contrast to the full inhibition of
cAMP-dependent Crh transcription by simultaneous knockdown of
CRTC2 and CRTC3 seen in rat hypothalamic 4B cells (Liu et al., 2010),
knocking down both CRTC isoforms in Y1-BS1 cells had no additive
eﬀect on Star transcription after 45min ACTH exposure. This suggests
CRTC2 and CRTC3 both act through a similar mechanism of action, and
that at the time of maximal Star transcription either CRTC2 of CRTC3
are capable of inducing full activation. However, it is possible that
diﬀerential recruitment of CRTC isoforms by the atypical Star half-CREs
(Luo et al., 2012; Song et al., 2018), due to diﬀerential aﬃnity with
pCREB or other mechanism (Conkright et al., 2003; Luo et al., 2012),
could have diﬀerent functional implications at earlier time points of
ACTH stimulation.
It is also evident from these experiments that other factors are
capable of mediating considerable ACTH-stimulation of Star transcrip-
tion in the absence of both CRTC2 and CRTC3. Although CRTC1 ex-
pression is far lower than that of CRTC2 and CRTC3 in rat (Fig. S1) and
human adrenals (Conkright et al., 2003), we show clear nuclear
translocation of CRTC1 following ACTH treatment, suggesting a pos-
sible role for CRTC1 in Star transcription. This could not be examined in
the present study because of the inability to knockdown CRTC1 protein
in Y1-BS1 cells, and future studies will be needed for elucidating the
potential role of CRTC1 on Star transcription. In addition, SF-1, which is
upregulated by ACTH (Ragazzon et al., 2006; Hazell et al., 2019), binds
the Star promoter and is necessary for cAMP-induced Star transcription
(Sandhoﬀ et al., 1998; Sugawara et al., 1997). Furthermore, subsets of
CREB-inducible genes can be alternatively regulated by CREB coacti-
vator CREB binding protein (CBP) (Kasper et al., 2010). The role of
these factors and their interaction with the transcriptional complex
during Star transcriptional initiation will require further investigation.
Investigation of signalling pathways showed that whilst MAPK ac-
tivation by EGF had no eﬀect on Star transcription in either Y1-BS1 or
ATC7-L cells, MEK inhibition by UO126 attenuated ACTH-induced Star
hnRNA in Y1-BS1 cells, but not ATC7-L cells. Furthermore, combination
of H89 and UO126 abolished Star transcriptional responses to ACTH in
Y1-BS1 cells, suggesting both pathways are required for full cAMP-de-
pendent stimulation of Star transcription in this cell line. Similar results
were found when using the PKA inhibitor PKI or MAPK inhibitor SL327
(Smith, Huang and Aguilera, unpublished observations). Previous stu-
dies also suggest cell-speciﬁc diﬀerences in the MAPK involvement in
Star transcriptional regulation; Lefrancois-Martinez et al. (2011) found
no eﬀect of MAPK inhibition on ACTH-stimulated StAR protein levels in
ATC1 cells, whilst, Gyles et al. (2001) showed inhibition of forskolin-
stimulated Star mRNA and protein by MEK inhibitors in Y1 cells.
Transactivation of the MAPK pathway by ACTH and cAMP has been
implicated in steroidogenesis (Gyles et al., 2001; Winnay and Hammer,
2006). Furthermore, consistent with previous reports (Le and
Schimmer, 2001), ACTH increased pERK levels in Y1-BS1 cells and, to a
lesser extent, ATC7-L cells (Smith, Olah and Aguilera, unpublished
observations).
H89 blunted ACTH-induced increases in nuclear CRTC, consistent
with the established cAMP dependence of CRTC activation and trans-
location to the nucleus (Bittinger et al., 2004; Takemori et al., 2007; Liu
et al., 2010). This was associated with complete inhibition of ACTH-
induced Star hnRNA at 10min, while there was a partial recovery by
30min. This is consistent with the eﬀects of siRNA CRTC knockdown, in
which there was only a partial reduction of Star hnRNA by 45min
ACTH stimulation, despite reduced CRTC2 and CRTC3 levels. Although
earlier Star hnRNA responses to ACTH were not measured in the siRNA
experiments, the overall ﬁndings strongly suggest that PKA/CRTC me-
chanisms are essential for early transcriptional activation of Star, and
that additional signalling mechanisms are important to sustain the ac-
tivation. The fact that MAPK appears to play a role in CRTC regulation
only in Y1-BS1 cells, raises a note a caution when extrapolating data
obtained from cell lines to in vivo regulation in various species.
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No eﬀect of PMA indicates PKC activation alone is insuﬃcient for
initiating Star transcription. PKC has previously been implicated in the
regulation of StAR protein levels in bovine adrenal cells (Nishikawa
et al., 1996), whilst low levels of steroidogenesis were previously in-
duced by 2 h incubation with PMA in Y1 cells (Frigeri and Armelin,
1996). Furthermore, Leydig M-10 cell studies have shown phorbol es-
ters increase Star mRNA levels (Manna and Stocco, 2005; Manna et al.,
2011). Ca2+-sensitive calcineurin can be activated by cAMP (Antoni,
1996), and it is known to activate CRTC (Bittinger et al., 2004; Lee
et al., 2015; Rahnert et al., 2016; Screaton et al., 2004). Thus, ACTH
signalling could lead to calcineurin activation and play a role in CRTC
activation and nuclear translocation in the adrenal fasciculata. How-
ever, CsA potentiated the eﬀect of ACTH on Star transcription, despite
attenuating ACTH-induced nuclear translocation of CRTC2. It is note-
worthy that Y1-BS1 cells lack part of the steroidogenic enzyme ex-
pression proﬁle, which characterises zona fasciculata cells (Bloch and
Cohen, 1960; Parker et al., 1985). The lost diﬀerentiation of these cells
may be responsible for the apparent dependence of Star transcription on
calcium (Lee et al., 2015) and MAPK signalling (Gyles et al., 2001), that
was not observed in ATC7-L cells in this study or elsewhere (Lefrancois-
Martinez et al., 2011; Schiebinger et al., 1985). Furthermore, CsA only
partially inhibits CRTC1 and CRTC2 translocation, suggesting PKA may
be the main mechanism regulating CRTC1 and CRTC2 activity. Al-
though less sensitive to calcium signalling than zona glomerulosa cells
(Braley et al., 1986; Omura et al., 2007; Spat et al., 2016), intracellular
calcium depletion in rat zona fasciculata cells blunts cAMP-induced
corticosterone release, suggesting that cAMP activation of adrenal
steroidogenesis in the adrenal fasciculata requires calcium release from
intracellular stores (Schiebinger et al., 1985).
This study provides evidence that of the 3 isoforms of CRTC present
in the adrenal fasciculata, at least CRTC2 and CRTC3 are involved in
the initiation of Star transcription. The rapid nuclear translocation and
recruitment by the Star promoter of CRTC2 and CRTC3 in response to
ACTH, preceding the maximal increases in Star primary transcript, and
the ability of siRNA knockdown of these CRTC isoforms to attenuate
ACTH-induced Star transcription, strongly suggest that PKA-mediated
activation of CRTC2 and CRTC3 plays a role in the initiation of Star
transcription. However, the fact that knockdown of both subtypes (or
preventing their activation by PKA inhibitors) reduces but does not
prevent ACTH-induced Star hnRNA increases, indicates the participa-
tion of additional factors and emphasizes the complexity of the me-
chanisms regulating StAR expression.
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